Solaredge Technologies Inc vs Summit Therapeutics Inc — how do they compare? Solaredge Technologies Inc trades at $50.15 (market cap $2.96B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Summit Therapeutics Inc is far larger — about 3.5× Solaredge Technologies Inc's market cap, and Solaredge Technologies Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SEDG | SMMT | |
|---|---|---|
Market Cap | $2.96B | $10.48B |
Sector | Technology | Health |
52-Week High | $78.51 | $29.32 |
52-Week Low | $24.42 | $13.05 |
Enterprise Value | $2.89B | $9.90B |
Trailing returns across standard periods
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →